Hims & Hers Health reported fourth quarter earnings that surpassed Wall Street expectations, posting earnings per share of $0.08 compared to analyst estimates of $0.05. The telehealth platform generated revenue of $617.8 million, representing 28% growth year over year and landing roughly in line with consensus forecasts of $618.7 million. Despite the earnings beat, investors […]

The postHims & Hers earnings beat but stock falls on guidanceappeared first onRolling Out.